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Estrogen receptor (ER) is a ligand-dependent transcriptional regulator. ER protein
has several functionally distinct regions, including a DNA-binding domain in its
midportion, a ligand binding domain in the carboxy terminal region, and at least one
domain, in the amino terminal region, that influences the magnitude of transcriptional
enhancement (1,2). We now report the sequence of a frequently occurring ER genetic
variant that carries two point mutations in the region of the gene encoding the amino
terminal domain of the protein.
In a previous study (3) using cRNA probes generated from subclones of a human ER cDNA
(4) we assayed the mRNA in human tissues that express the gene. Solution
hybridization/RNase protection revealed a genetic polymorphism within the mRNA region
encoding the amino terminal portion of the protein (3). ER-positive human breast tumors
that were heterozygous for the variant gene contained, on average, lower concentrations
of ER than tumors obtained from homozygous wild type samples, suggesting that the variant
gene may produce less ER or a less stable form of the protein.
To determine the sequence of the ER gene variant region, this portion (from
nucleotide 189 to 366 downstream from the initiation codon) (3) was amplified from
genomic DNA obtained from three heterozygotes. Taq polymerase-catalyzed DNA
amplification (5) made use of two synthetic DNA primers: ERI) 5'-CtgcaGCGCAGGTC
TACGGTCAGACC-3' and ER2) 5'AGCaAGCTtCGGCGGCGGGTGCAGT-3'. (Small letters
indicate bases included in the primers to generate PstI and HindIll restriction sites at
the ends of the amplified products.) Amplified products were treated with restriction
enzymes and ligated to pGEM3 plasmid DNA. Bacteria were transformed with these DNAs, and
recombinant plasmids from each template were sequenced (6). Sequences were either wild
type or contained two point mutations, at nucleotides 257 (C-T transition, changing Ala
86 to Val) and 261 (G-C transition, a silent mutation).
While functional significance of the human ER variant remains to be established, we
note that the protein sequence of the wild type human ER between amino acids 80 and 89 is
identical to that in rat and mouse ER (7,8). The change at nucleotide 257 in the variant
human ER removes a BbvI restriction enzyme site and thus provides a method for detecting
the variant ER gene in genomic DNA samples.
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